Terminal deoxynucleotidyl transferase (TDT) pair capable of split recombination, and construction method
By designing the cleavable and recombinable TdT-D1 and TdT-D2 domains, the photoresponsive protein elements are used to regulate enzyme activity under blue light, the problem of protectant dependence in existing DNA synthesis methods is solved, and the DNA synthesis process is simplified and automation.
Patent Information
- Application Number
- PCT/CN2023/097888
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-25
- Filing Date
- 2023-06-01
- Publication Date
- 2024-11-28
AI Technical Summary
The existing TdT-based DNA synthesis methods require reliance on protective agents and deprotective agents, which leads to the complex DNA synthesis process and limits the degree of automation of enzymatic DNA synthesis.
A pair of cleavable and recombinable terminal deoxynucleotide nucleic acid transferases were designed to regulate the catalytic activity of the enzyme through the interaction of TdT-D1 and TdT-D2, and the light-responsive protein elements pMag and nMag were used to make TdT-D1 and TdT under blue light. -D2 recombination to achieve flexible regulation of enzyme activity.
The cycling steps of DNA synthesis are simplified, the dependence on protectors and deprotectants is avoided, and the degree of automation and flexibility of DNA synthesis is improved.
Smart Images

Figure CN2023097888_28112024_PF_FP_ABST
Abstract
Description
A pair of terminal deoxynucleotidyl transferases capable of cleavage and recombination and a construction method thereof Technical Field
[0001] The present invention relates to the field of biotechnology, in particular to a pair of terminal deoxynucleotidyl transferases capable of splitting and recombining, and a construction method and application thereof. Background Art
[0002] Artificial DNA synthesis technology is an important foundation of modern genetic technology. Key methods for artificial DNA synthesis include: column-based chemical oligonucleotide synthesis, chip-based chemical oligonucleotide synthesis, oligonucleotide purification, oligonucleotide assembly, gene synthesis error correction and clone screening, large-fragment gene synthesis assembly, and the next generation of enzymatic DNA synthesis. Traditional methods for artificial DNA synthesis mostly rely on phosphoramidite chemistry to complete the reaction. In recent years, the third generation of artificial DNA synthesis based on enzymatic synthesis has gradually emerged as a promising method for artificial DNA synthesis. Among them, enzymatic synthesis technology based on terminal deoxyribonucleoside transferase (TdT) is a very promising DNA synthesis strategy.
[0003] A novel enzymatic nucleotide synthesis method utilizes the template-independent DNA terminal nucleoside transferase (TdT) to synthesize oligonucleotide fragments in vitro. Bollum first discovered TdT and proposed its application in the synthesis of single-stranded oligonucleotides. Subsequently, Schott and Schrade discovered that TdT has minimal preference for the four nucleotides and exhibits high coupling efficiency, enabling processive synthesis and extension of single-stranded DNA to produce homopolymers up to 8000 nt. To achieve controlled DNA synthesis catalyzed by TdT, the activity of the DNA synthesizer must be reversibly controlled. The TdT catalytic activity control mechanism constructed by Keasling's team in 2018 utilizes a reversible covalent bond between TdT and a single nucleotide to prevent further extension of the DNA chain synthesized by TdT. Breaking this reversible covalent bond allows the DNA chain to enter a new nucleotide addition cycle. This method achieves an average coupling efficiency of 97.7%, and a single cycle takes 2–3 minutes. DNA synthesis based on this innovative TdT has garnered widespread attention from both academia and industry.
[0004] Due to the increasingly significant application of TdT in DNA synthesis, the significance of conducting enzyme engineering design for TdT to achieve flexible regulation of TdT enzyme activity has gradually become prominent. The existing methods for regulating TdT enzyme activity are limited, mainly relying on artificially modified specific deoxyribonucleotides as TdT substrates and adding protective groups to the 3'-OH of the substrate molecule. The steric hindrance formed by this protective group effectively blocks the connection process of the next substrate monomer. However, when adding the next base, the protective group at the 3' end needs to be deprotected before the next cycle reaction can be carried out. Therefore, the existing TdT-based DNA synthesis still requires multiple reactions to achieve, which limits the degree of automation of enzymatic DNA synthesis.
[0005] To address this problem, the present invention designs a TdT domain that can split and recombine, thereby significantly regulating the catalytic activity of the TdT enzyme by controlling the interaction of the TdT protein domains (TdT-D1, TdT-D2), eliminating the need to rely on protecting agents and deprotecting agents.
[0006] Therefore, the existing technology still needs to be improved and developed.
[0007] Summary of the Invention
[0008] In view of the above-mentioned deficiencies in the prior art, the present invention aims to provide a pair of cleavable and recombinable terminal deoxynucleotidyl transferases, as well as construction methods and applications, in order to address the problem that existing methods for regulating TdT enzyme activity require reliance on protecting agents and deprotecting agents, resulting in TdT-based DNA synthesis still requiring multiple steps.
[0009] The technical solutions of the present invention are as follows:
[0010] A pair of cleavable and recombinable terminal deoxynucleotidyl transferases, comprising two TdT protein domains obtained by cleavage of TdT, the two TdT protein domains being designated TdT-D1 and TdT-D2, respectively. When the TdT-D1 and TdT-D2 exist separately, they do not independently exhibit TdT catalytic activity; when the TdT-D1 and TdT-D2 exist simultaneously and in proximity, TdT-D1 and TdT-D2 will recombine and exhibit TdT catalytic activity.
[0011] Optionally, the N-terminus of the TdT-D1 is connected to pMag, which is recorded as pMag-TdT-D1; the C-terminus of the TdT-D2 is connected to nMag, which is recorded as TdT-D2-nMag;
[0012] Before blue light irradiation, the pMag-TdT-D1 and TdT-D2-nMag do not independently exhibit TdT catalytic activity when present alone;
[0013] Under blue light irradiation, pMag and nMag dimerize and bring TdT-D1 and TdT-D2 into proximity, causing TdT-D1 and TdT-D2 to recombine and exhibit TdT catalytic activity.
[0014] Optionally, the molar ratio of pMag-TdT-D1 to TdT-D2-nMag is 1:1.
[0015] Optionally, the N-terminus of the TdT-D1 is connected to pMag via a first linker, and the C-terminus of the TdT-D2 is connected to nMag via a first linker, and the amino acid sequence of the first linker is GSGGSGGSGGSG.
[0016] Optionally, the two TdT protein domains obtained by cleaving TdT specifically include: two TdT protein domains obtained by cleaving the remaining TdT after deleting 1-146 amino acids without substantial catalytic function from TdT.
[0017] The amino acid sequence of TdT is shown in SEQ ID NO. 1. After deleting amino acids 1-146 that have no substantial catalytic function from TdT, the remaining amino acid sequence of TdT is shown in SEQ ID NO. 2.
[0018] Optionally, the amino acid sequence of the TdT-D1 is shown as SEQ ID NO.3, and the amino acid sequence of the TdT-D2 is shown as SEQ ID NO.4.
[0019] Optionally, the amino acid sequence of the pMag-TdT-D1 is shown as SEQ ID NO.5, and the amino acid sequence of the TdT-D2-nMag is shown as SEQ ID NO.6.
[0020] A method for constructing the cleavable and recombinant terminal deoxynucleotidyl transferase of the present invention, comprising the steps of:
[0021] Provide TdT;
[0022] The N-terminus and C-terminus of the TdT are connected by a second linker, and cleavage sites are selected step by step starting from the N-terminus on the TdT to construct different TdT variants;
[0023] Screening TdT variants with high expression levels and high catalytic activity from different TdT variants to obtain candidate TdT variants;
[0024] The second linker in the candidate TdT variant is removed to obtain TdT-D1 and TdT-D2, and when the TdT-D1 and TdT-D2 exist separately, they do not independently exhibit TdT catalytic activity; when the TdT-D1 and TdT-D2 exist simultaneously and in close proximity, TdT-D1 and TdT-D2 will recombine and exhibit TdT catalytic activity.
[0025] Optionally, the amino acid sequence of the second linker is GTGGSGGTGG;
[0026] After obtaining the TdT-D1 and TdT-D2, the method further includes the steps of connecting the light-responsive protein element pMag and the light-responsive protein element nMag to the N-terminus of TdT-D1 and the C-terminus of TdT-D2, respectively, to obtain pMag-TdT-D1 and TdT-D2-nMag.
[0027] The invention discloses an application of a pair of terminal deoxynucleotidyl transferases capable of splitting and recombining to catalyze DNA synthesis reaction.
[0028] Beneficial effects: The cleavable and recombinant TdT proposed in the present invention is composed of two TdT protein domains (TdT-D1 and TdT-D2), which do not exhibit observable DNA synthesis catalytic activity when existing separately; but when the two protein domains are close to each other, TdT-D1 and TdT-D2 will recombine and exhibit DNA synthesis catalytic activity. The present invention designs a cleavable and recombinant TdT, and achieves flexible regulation of TdT enzyme activity by regulating the relative distance between TdT-D1 and TdT-D2. Enzymatic DNA synthesis based on TdT-D1 and TdT-D2 no longer needs to rely on protecting agents and deprotecting agents to achieve regulation of DNA synthase activity, thereby significantly simplifying the cyclic steps of artificial DNA synthesis. BRIEF DESCRIPTION OF THE DRAWINGS
[0029] FIG1 is a schematic flow chart of a method for constructing a pair of cleavable and recombinant terminal deoxynucleotidyl transferases provided in an embodiment of the present invention.
[0030] FIG2 is a schematic diagram of the process for designing the cleavable and recombinable TdT-D1 and TdT-D2 from the wild-type wtZaTdT, as well as obtaining the light-regulated cleavable and recombinable pMag-TdT-D1 and TdT-D2-nMag.
[0031] FIG3 is a schematic diagram of using the cleavable and recombinant TdT-D1 and TdT-D2 protein domains to construct pMag-TdT-D1 and TdT-D2-nMag whose TdT enzyme catalytic activity is regulated by light.
[0032] Figure 4A is a schematic diagram of the catalytic activity exhibited by the TdT-D1 and TdT-D2 protein domains when linked by a linker (D1-Linker-D2); Figure 4B is a schematic diagram of the catalytic activity exhibited by pMag-TdT-D1 and TdT-D2-nMag alone, when mixed in the dark state, and after mixing in the light state. DETAILED DESCRIPTION
[0033] The present invention provides a pair of cleavable and recombinant terminal deoxynucleotidyl transferases, as well as methods for their construction and use. To clarify the objectives, technical solutions, and effects of the present invention, the present invention is described in further detail below. It should be understood that the specific embodiments described herein are intended only to illustrate the present invention and are not intended to limit the present invention.
[0034] Terminal deoxynucleotidyl transferase (TdT) is an important tool for the enzymatic synthesis of oligonucleotides. Flexible regulation of the catalytic activity of TdT enzyme is of great significance for the controllable artificial enzymatic synthesis of DNA, but there is currently a lack of strategies to flexibly regulate the activity of TdT enzyme.
[0035] Existing methods for regulating TdT enzyme activity are limited, primarily relying on artificially modified specific deoxyribonucleotides as TdT substrates and the addition of protective groups to the 3'-OH group of the substrate molecule. The steric hindrance created by this protective group effectively blocks the attachment process of the next substrate monomer. However, before the next base is added, the protective group at the 3' end must be deprotected before the next cycle reaction can proceed. Therefore, existing TdT-based DNA synthesis still requires multiple reactions, limiting the degree of automation of enzymatic DNA synthesis.
[0036] To address this technical problem, the present invention proposes a pair of cleavable and recombinable TdT protein domains, which significantly regulate the catalytic activity of the TdT enzyme by controlling the interaction between the TdT protein domains (TdT-D1, TdT-D2), eliminating the need to rely on protecting agents and deprotecting agents.
[0037] Specifically, an embodiment of the present invention provides a pair of cleavable and recombinable terminal deoxynucleotidyl transferases, which include two TdT protein domains obtained by cleavage of TdT, and the two TdT protein domains are respectively recorded as TdT-D1 and TdT-D2. When the TdT-D1 and TdT-D2 exist separately, they do not independently exhibit TdT catalytic activity; when the TdT-D1 and TdT-D2 exist at the same time and are close to each other, TdT-D1 and TdT-D2 will recombine and exhibit TdT catalytic activity.
[0038] This example designs a cleavable and recombinable TdT. By regulating the relative distance between TdT-D1 and TdT-D2, flexible regulation of TdT enzyme activity is achieved. Enzymatic DNA synthesis based on TdT-D1 and TdT-D2 no longer requires the use of protecting and deprotecting agents to achieve regulation of DNA synthase activity, significantly simplifying the DNA synthesis cycle. This example provides a new model for flexible and simple regulation of TdT enzyme activity.
[0039] In one embodiment, the N-terminus of the TdT-D1 is connected to pMag, which is denoted as pMag-TdT-D1; the C-terminus of the TdT-D2 is connected to nMag, which is denoted as TdT-D2-nMag;
[0040] Before blue light irradiation, the pMag-TdT-D1 and TdT-D2-nMag do not independently exhibit TdT catalytic activity when present alone;
[0041] Under blue light irradiation, pMag and nMag dimerize and bring TdT-D1 and TdT-D2 into proximity, causing TdT-D1 and TdT-D2 to recombine and exhibit TdT catalytic activity.
[0042] This example modulates DNA synthase activity by regulating the interaction force and distance between TdT-D1 and TdT-D2 proteins. pMag and nMag are a pair of photosensitive protein domains whose mutual affinity is regulated by light and can dimerize under blue light. This example achieves dimerization of TdT-D1 and TdT-D2 under light conditions by fusing pMag and nMag to the ends of the TdT-D1 and TdT-D2 proteins, thereby creating a light-regulated pMag-TdT-D1 and TdT-D2-nMag pair. Under blue light irradiation, the catalytic activity of pMag-TdT-D1 and TdT-D2-nMag combinations at different ratios was tested and compared with the catalytic activity of wild-type TdT. The experimental results showed that pMag-TdT-D1 and TdT-D2-nMag exhibited TdT enzyme catalytic activity after illumination, but did not exhibit any observable enzyme catalytic activity before illumination.
[0043] In one embodiment, the molar ratio of pMag-TdT-D1 to TdT-D2-nMag is 1: 1. Within this ratio range, the combination of pMag-TdT-D1 and TdT-D2-nMag exhibits higher TdT enzyme catalytic activity.
[0044] In one embodiment, the N-terminus of the TdT-D1 is connected to pMag via a first linker, and the C-terminus of the TdT-D2 is connected to nMag via a first linker, and the amino acid sequence of the first linker is GSGGSGGSGGSG.
[0045] In one embodiment, the two TdT protein domains obtained by cleavage of TdT specifically include: two TdT protein domains obtained by cleavage of the remaining TdT after deleting 1-146 amino acids without substantial catalytic function from TdT.
[0046] This example, based on the protein sequence and 3D structure of TdT, first deleted amino acids 1-146 of TdT, which have no substantial catalytic function, based on the 3D structural and functional analysis of TdT. Then, based on the remaining protein domains, two recombinant TdT protein domains were obtained: TdT-D1 and TdT-D2.
[0047] In one embodiment, the amino acid sequence of TdT is as shown in SEQ ID NO.1, and after deleting amino acids 1-146 that have no substantial catalytic function from TdT, the remaining amino acid sequence of TdT is as shown in SEQ ID NO.2.
[0048] In one embodiment, the amino acid sequence of the TdT-D1 is shown as SEQ ID NO.3, and the amino acid sequence of the TdT-D2 is shown as SEQ ID NO.4.
[0049] In one embodiment, the amino acid sequence of the pMag-TdT-D1 is shown as SEQ ID NO.5, and the amino acid sequence of the TdT-D2-nMag is shown as SEQ ID NO.6.
[0050] The present invention provides a method for constructing a pair of terminal deoxynucleotidyl transferases capable of cleavage and recombination, as shown in FIG1 , comprising the steps of:
[0051] S1. Provide TdT;
[0052] S2. Connecting the N-terminus and C-terminus of the TdT using a second linker (a flexible linker), selecting cleavage sites on the TdT starting from the N-terminus, and constructing different TdT variants;
[0053] S3. Screening TdT variants with high expression levels and high catalytic activity from different TdT variants to obtain candidate TdT variants;
[0054] S4. Removing the second linker from the candidate TdT variant to obtain TdT-D1 and TdT-D2, wherein the TdT-D1 and TdT-D2 do not independently exhibit TdT catalytic activity when they exist alone; when the TdT-D1 and TdT-D2 exist simultaneously and in close proximity, TdT-D1 and TdT-D2 will recombine and exhibit TdT catalytic activity.
[0055] In step S2, in one embodiment, before the step of connecting the N-terminus and the C-terminus of the TdT with a second linker, the step further comprises:
[0056] Based on the 3D structure and functional analysis of TdT, amino acids 1-146 of TdT that have no substantial catalytic function were deleted.
[0057] This example is based on the protein sequence and 3D structure of TdT. First, based on the 3D structure and functional analysis of TdT, the 1-146 amino acids of TdT that have no substantial catalytic function were deleted. Subsequently, based on the remaining protein domains, two recombinant TdT protein domains were obtained: TdT-D1 and TdT-D2. Both TdT-D1 and TdT-D2 contain a portion of the structure of TdT, but do not independently exhibit TdT catalytic activity when they exist alone (i.e., they do not exhibit DNA synthesis catalytic activity). When TdT-D1 and TdT-D2 are present simultaneously and in close proximity, TdT-D1 and TdT-D2 can be recombined to form catalytically active TdT.
[0058] That is, after deleting the 1-146 amino acids of TdT that have no substantial catalytic function, the flexible loop region (flexible loop) and potential cleavage sites of the remaining TdT protein were analyzed. The domain from the original N-terminus of TdT to the cleavage site is TdT-D1, and the domain from the cleavage site to the original C-terminus of TdT is TdT-D2. TdT-D1 and TdT-D2 that cut in different flexible loop regions were constructed, and it was confirmed that the selection of the cleavage site can enable TdT-D1 and TdT-D2 to be recombined into catalytically active TdT after the spatial distance is forced to be shortened by the linker.
[0059] The library design and screening of TdT-D1 and TdT-D2 are as follows:
[0060] To identify suitable cleavage sites, the N- and C-termini of TdT were linked using a second linker (GTGGSGGTGG). Starting from the N-terminus of the original TdT, cleavage sites were selected step by step to construct different TdT variants. These TdT variants with novel N- and C-termini were tested for expression levels and catalytic activity, with those with high expression levels and relatively high catalytic activity being prioritized. After generating candidate TdT variants, the flexible linker (GTGGSGGTGG) between the original N- and C-termini of TdT was removed to generate separate forms, TdT-D1 and TdT-D2. The catalytic activities of TdT-D1 and TdT-D2 were then verified. Experiments demonstrated that TdT-D1 and TdT-D2 did not exhibit TdT catalytic activity independently. However, when linked by a linker (TdT-D1-linker-TdT-D2), TdT-D1 and TdT-D2 could reconstitute to form catalytically active TdT. The linker may be GTGGSGGTGG, and of course a flexible linker composed of GGTGGS units is also applicable.
[0061] In this embodiment, after obtaining TdT-D1 and TdT-D2, the following steps may be further included: connecting the light-responsive protein element pMag and the light-responsive protein element nMag to the N-terminus of TdT-D1 and the C-terminus of TdT-D2, respectively, to obtain pMag-TdT-D1 and TdT-D2-nMag, thereby obtaining a combination TdT whose catalytic activity is regulated by light. Under blue light irradiation, pMag and nMag will dimerize and bring TdT-D1 and TdT-D2 into proximity, thereby recombining into TdT with enzymatic catalytic activity. Specifically, under blue light irradiation, pMag-TdT-D1 and TdT-D2-nMag exhibit enzymatic activity, but do not exhibit observable enzymatic activity individually before light irradiation.
[0062] The embodiment of the present invention provides the use of a pair of cleavable and recombinant terminal deoxynucleotidyl transferases as described above to catalyze DNA synthesis reactions.
[0063] In this embodiment, the enzymatic DNA synthesis based on TdT-D1 and TdT-D2 no longer needs to rely on protecting agents and deprotecting agents to achieve the regulation of DNA synthase activity, thereby significantly simplifying the cycle steps of DNA synthesis.
[0064] The present invention will be further described below with reference to specific examples.
[0065] 1. Library design of TdT-D1 and TdT-D2
[0066] As shown in Figure 2, based on the protein sequence and 3D structure of wild-type ZaTdT, amino acids 1-146 that have no substantial catalytic function in wild-type ZaTdT were deleted. The N-terminus and C-terminus of TdT were connected using a flexible linker (GTGGSGGTGG), and cleavage sites were selected section by section starting from the N-terminus of the original TdT to construct different TdT variants. Expression levels and catalytic activity tests were performed on these TdT variants with new N-termini and C-termini, and TdT variants with high expression levels and relatively high catalytic activity were preferentially selected. After obtaining the candidate TdT variants, the flexible linker (GTGGSGGTGG) between the original N-terminus and C-terminus of TdT was removed to obtain the separated forms of TdT-D1 and TdT-D2 as shown in Figure 2, and the catalytic activity of TdT-D1 and TdT-D2 was verified.
[0067] TdT-D1, TdT-D2, pMag-TdT-D1, and TdT-D2-nMag transformation and protein purification steps: 1 μL of correctly sequenced plasmid was added to E. coli BL21 (DE3) competent cells. After incubation on ice for 30 minutes, the cells were heat-shocked in a 42°C water bath for 45 seconds, immediately removed and placed on ice for 5 minutes. 500 μL of BL medium was added and the cells were incubated at 190 rpm in a 37°C incubator for 50 minutes. The cells were centrifuged at 10,000 rpm for 1 minute, and the precipitated cells were evenly spread on a culture dish and placed in an incubator overnight. Single colonies were picked the next day.
[0068] A single clone mutant was selected and incubated in 200 mL of LB medium containing 100 μg / mL kanamycin for 3 hours until the OD600 value was 0.6; IPTG (isopropyl-β-d-thiogalactose) was added to a final concentration of 0.5 mM, and the cells were induced at 230 rpm at 16°C overnight; the cells were collected by centrifugation at 6000 g for 10 min and then resuspended in 50 mL of lysis buffer (30 mM Tris-HCl buffer, 500 mM NaCl, 20 mM imidazole); the cells were lysed using a high-pressure homogenizer, centrifuged at 6000 g for 10 min at 4°C to remove cell debris, and the clarified lysate was passed through a nickel affinity chromatography column under gravity; non-target proteins were removed with 50 mL of wash buffer (30 mM Tris-HCl buffer, 200 mM NaCl, 40 mM imidazole), and then washed with 5 mL of elution buffer (30 mM Tris-HCl buffer, 200 mM The target proteins were collected by centrifugation with 1% NaCl, 200 mM imidazole, and the eluted proteins were concentrated and dialyzed using a 30 kDa molecular weight ultrafiltration centrifugal column to obtain purified TdT-D1, TdT-D2, pMag-TdT-D1, and TdT-D2-nMag.
[0069] Catalytic activity test of TdT-D1 and TdT-D2 (denatured urea polyacrylamide gel electrophoresis, denatured urea PAGE):
[0070] Add oligonucleotide primers, deoxyribonucleotides, and CoCl2 to HEPES buffer to prepare a reaction solution containing 1 μM oligonucleotide primers, 0.1 mM deoxyribonucleotides, and 0.25 mM CoCl2, and store in a 30°C metal bath until use;
[0071] 1 μL of 0.5 mg / mL TdT-D1, TdT-D2, and a mixed sample of TdT-D1+TdT-D2 were added to 20 μL of the reaction preparation solution, mixed evenly with a pipette, reacted at 37°C for 30 min, and then stopped by heating at 95°C for 15 s. 5 μL of the reaction solution was mixed with 5 μL of 2X loading buffer to obtain the test sample. 10 mL of 15% urea denaturing gel was prepared and poured between the glass plates of the gel rack and a sample comb was inserted. The electrophoresis system was assembled, TBE electrophoresis buffer was added, the sample comb was removed, and a marker and the test sample were added to the sample well. Electrophoresis was performed at a constant voltage of 200 V for 60 min. The results were observed under a gel imager. Oligonucleotide primers and wt ZaTdT were used as controls for this activity test.
[0072] 2. Verification of the catalytic activity of TdT-D1 and TdT-D2
[0073] Recombinant TdT-D1 and TdT-D2 expression plasmids were used to express the corresponding proteins in Escherichia coli. Purified TdT-D1 and TdT-D2 proteins were obtained using protein isolation techniques. The enzymatic activity of TdT-D1 and TdT-D2, both alone and in combination, was characterized using a TdT enzyme activity characterization method. TdT-D1 and TdT-D2 were selected for their catalytic activity, which was absent in their individual forms but exhibited significant catalytic activity in combination.
[0074] 3. As shown in Figure 3, pMag and nMag were fused to the ends of the TdT-D1 and TdT-D2 proteins, respectively, to construct the corresponding recombinant expression plasmids. Under blue light irradiation, the catalytic activity of different combinations of pMag-TdT-D1 and TdT-D2-nMag was tested and compared with the catalytic activity of wild-type TdT. The experimental results showed that after illumination, when pMag-TdT-D1 and TdT-D2-nMag were co-present in the reaction system, they exhibited significant TdT enzyme catalytic activity, but no individual enzyme catalytic activity was observed before illumination.
[0075] 4. Catalytic activity test of pMag-TdT-D1 and TdT-D2-nMag (denatured urea polyacrylamide gel electrophoresis, denatured urea PAGE):
[0076] Add oligonucleotide primers, deoxyribonucleotides, and CoCl2 to HEPES buffer to prepare a reaction solution containing 1 μM oligonucleotide primers, 0.1 mM deoxyribonucleotides, and 0.25 mM CoCl2, and store in a 30°C metal bath until use;
[0077] 1 μL of 0.5 mg / mL pMag-TdT-D1, TdT-D2-nMag mutant, and pMag-TdT-D1+TdT-D2-nMag mixed mutant samples were added to 20 μL of reaction preparation solution, mixed evenly with a pipette, and reacted at 37°C under blue light and in the dark for 30 min, respectively, and then stopped by heating at 95°C for 15 s. 5 μL of the reaction solution was mixed with 5 μL of 2X loading buffer to obtain the test sample. 10 mL of 15% urea denaturing gel was prepared and poured between the glass plates of the gel rack and a sample comb was inserted. The electrophoresis system was assembled, TBE running buffer was added, the sample comb was removed, and a marker and the test sample were added to the sample well. Electrophoresis was performed at a constant voltage of 200 V for 60 min, and the results were observed on a gel imager. Oligonucleotide primers and wt ZaTdT were used as controls in this activity test.
[0078] The test results are as follows:
[0079] As shown in Figure 4A, the TdT-D1 and TdT-D2 protein domains have no DNA synthase catalytic activity when they exist alone, but exhibit significant catalytic activity when linked by a linker (D1-Linker-D2).
[0080] As shown in FIG4B , pMag-TdT-D1 and TdT-D2-nMag had no DNA synthase catalytic activity when they existed alone or when they were mixed in the dark state, but exhibited significant DNA synthase catalytic activity when they were mixed in the light state.
[0081] The sequences involved in this embodiment are as follows:
[0082] SEQ ID NO.1: Wild-type ZaTdT
[0083] SEQ ID NO.2: The remaining protein domain after deleting amino acids 1-146 of wild-type ZaTdT that have no substantial catalytic function
[0084] SEQ ID NO.3: TdT-D1
[0085] SEQ ID NO.4: TdT-D2
[0086] SEQ ID NO.5: pMag-TdT-D1
[0087] SEQ ID NO.6: TdT-D2-nMag
[0088] In summary, the present invention provides a pair of cleavable and recombinable terminal deoxynucleotidyl transferases, as well as construction methods and applications. The present invention designs a cleavable and recombinable TdT, and by regulating the relative distance between TdT-D1 and TdT-D2, flexible regulation of TdT enzyme activity is achieved. Enzymatic DNA synthesis based on TdT-D1 and TdT-D2 no longer requires the reliance on protecting and deprotecting agents to achieve regulation of DNA synthase activity, thereby significantly simplifying the cyclic steps of artificial DNA synthesis. This method also provides a new model for flexible and simple regulation of TdT enzyme activity.
[0089] It should be understood that the application of the present invention is not limited to the above examples. For those skilled in the art, improvements or changes can be made based on the above description. All these improvements and changes should fall within the scope of protection of the claims attached to the present invention.
Claims
1. A pair of terminal deoxynucleotidyl transferases that can split and recombine, It is characterized in that It includes two TdT protein domains obtained by cutting TdT, and the two TdT protein domains are respectively recorded as TdT-D1 and TdT-D2. When the TdT-D1 and TdT-D2 exist separately, they do not independently exhibit TdT catalytic activity; when the TdT-D1 and TdT-D2 exist at the same time and are close to each other, TdT-D1 and TdT-D2 will recombine and exhibit TdT catalytic activity.
2. A pair of terminal deoxynucleotidyl transferases capable of cleavage and recombination according to claim 1, It is characterized in that The N-terminus of the TdT-D1 is connected to pMag, which is recorded as pMag-TdT-D1; the C-terminus of the TdT-D2 is connected to nMag, which is recorded as TdT-D2-nMag; Before blue light irradiation, the pMag-TdT-D1 and TdT-D2-nMag do not independently exhibit TdT catalytic activity when present alone; Under blue light irradiation, pMag and nMag dimerize and bring TdT-D1 and TdT-D2 close to each other, and TdT-D1 and TdT-D2 recombine and exhibit TdT catalytic activity.
3. A pair of terminal deoxynucleotidyl transferases capable of cleavage and recombination according to claim 2, It is characterized in that The molar ratio of pMag-TdT-D1 and TdT-D2-nMag is 1:
1.
4. A pair of terminal deoxynucleotidyl transferases capable of cleavage and recombination according to claim 2, It is characterized in that The N-terminus of the TdT-D1 is connected to pMag via a first linker, and the C-terminus of the TdT-D2 is connected to nMag via a first linker, wherein the amino acid sequence of the first linker is GSGGSGGSGGSG.
5. A pair of terminal deoxynucleotidyl transferases capable of cleavage and recombination according to claim 1, It is characterized in that The two TdT protein domains obtained by cleaving TdT specifically include: two TdT protein domains obtained by cleaving the remaining TdT after deleting 1-146 amino acids without substantial catalytic function; The amino acid sequence of the TdT is shown in SEQ ID NO.1, and after deleting amino acids 1-146 that have no substantial catalytic function from the TdT, the remaining amino acid sequence of the TdT is shown in SEQ ID NO.
2.
6. A pair of terminal deoxynucleotidyl transferases capable of cleavage and recombination according to claim 1, It is characterized in that The amino acid sequence of the TdT-D1 is shown in SEQ ID NO.3, and the amino acid sequence of the TdT-D2 is shown in SEQ ID NO.
4.
7. A pair of terminal deoxynucleotidyl transferases capable of cleavage and recombination according to claim 3, It is characterized in that The amino acid sequence of the pMag-TdT-D1 is shown in SEQ ID NO.5, and the amino acid sequence of the TdT-D2-nMag is shown in SEQ ID NO.
6.
8. A method for constructing the cleavable and recombinant terminal deoxynucleotidyl transferase according to claim 1, It is characterized in that Includes steps: Provide TdT; The N-terminus and the C-terminus of the TdT are connected by a second linker, and the cleavage sites are selected segment by segment starting from the N-terminus on the TdT to construct different TdT variants; Screening TdT variants with high expression levels and high catalytic activity from different TdT variants to obtain candidate TdT variants; The second linker in the candidate TdT variant is removed to obtain the TdT-D1 and TdT-D2, and when the TdT-D1 and TdT-D2 exist separately, they do not independently exhibit TdT catalytic activity; when the TdT-D1 and TdT-D2 exist at the same time and are close to each other, TdT-D1 and TdT-D2 will recombine and exhibit TdT catalytic activity.
9. The method for constructing a pair of terminal deoxynucleotidyl transferases capable of cleavage and recombination according to claim 8, It is characterized in that The amino acid sequence of the second linker is GTGGSGGTGG; After obtaining the TdT-D1 and TdT-D2, the method further comprises the steps of connecting the light-responsive protein element pMag and the light-responsive protein element nMag to the N-terminus of TdT-D1 and the C-terminus of TdT-D2, respectively, to obtain pMag-TdT-D1 and TdT-D2-nMag.
10. Use of a pair of cleavable and recombinant terminal deoxynucleotidyl transferases as claimed in any one of claims 1 to 7 to catalyze DNA synthesis reactions.
Citation Information
Patent Citations
Use of terminal transferase enzyme in nucleic acid synthesis
CN110997907A
New function and application of nucleoside transferase
CN112746063A
MODIFIED TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE (TdT) ENZYMES
CN113454212A
Recombinant terminal deoxynucleotidyl transferase with improved functionality
US20040043396A1
